Sign in / Join Now
ETFs & Funds
Sharon di Stefano
Pluristem's Preeclampsia Effort Pushes PLX Platform $
Add a reply...
Latest StockTalks »
people get PSTI breaking news and analysis by email alert.
Get email alerts on PSTI »
Pluristem Therapeutics, Inc.
Get latest price
From other sites
Pluristem Receives Clearance From Germany To Initiate Its Multinational Phase III Trial In Critical Limb Ischemia Targeting Early Conditional Marketing Approval
at TheStreet (Tue, 5:30AM)
Pluristem Completes Patient Enrollment In A Large Multinational Phase II Trial In Intermittent Claudication
at TheStreet (Thu, 6:00AM)
Pluristem's Phase III Study Of PLX-PAD Cells For The Treatment Of Critical Limb Ischemia Cleared By U.S. FDA
at TheStreet (Jan 10, 2017)
Pluristem And New York Blood Center To Collaborate In Evaluating PLX-R18 As An Adjuvant Therapy To Umbilical Cord Blood Transplantation, Winning $900,000 Funding From BIRD
at TheStreet (Dec 27, 2016)
Pluristem And Innovative Medical Management Co., Ltd. Mutually Agree To Extend The Time To Execute The Definitive Investment Agreements Due To New Chinese Monetary Policy
at TheStreet (Dec 23, 2016)